Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients.
Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients.
复制标题
DOI:
10.1016/j.ijcha.2022.101114
复制
发表时间:
2022-10
影响因子:
2.9
通讯作者:
Nakajima, Toshiaki
中科院分区:
文献类型:
--
作者:
Nishikawa, Riichi;Fukuda, Taira;Haruyama, Akiko;Shibasaki, Ikuko;Yamaguchi, Suomi;Arikawa, Takuo;Obi, Syotaro;Amano, Hirohisa;Yagi, Hiroshi;Sakuma, Masashi;Abe, Shichiro;Fukuda, Hirotsugu;Toyoda, Shigeru;Nakajima, Toshiaki
Myostatin is a negative regulator of skeletal muscle mass. On the other hand, growth differentiation factor (GDF)-15 is associated with lower muscle strength and muscle mass. We investigated the relationship between serum GDF-15, myostatin, and sarcopenia in patients receiving cardiovascular surgery through a ROC curve and a multivariate regression analysis. Skeletal muscle mass index (SMI) by bioelectrical impedance analysis, hand-grip strength, knee extension strength, and walking speed were measured. Preoperative serum GDF-15 and myostatin levels were determined by ELISA. The sarcopenia index could be expressed as: −0.0042 × [myostatin] + 0.0007 × [GDF-15] + 0.0890 × age + 1.4030 × sex − 0.2679 × body mass index (BMI) − 2.1186. A ROC curve was plotted to identify the optimal cutoff level of the sarcopenia index to detect sarcopenia. 120 patients receiving cardiovascular surgery were included in the study. SMI, hand-grip strength, knee extension strength, and walking speed inversely correlated with GDF-15, but positively correlated with myostatin. In the multivariate stepwise regression analysis, SMI was a determinant of myostatin, and both GDF-15 and myostatin were determinants of SMI and muscle thickness, even after adjustment for age, sex, and BMI. A ROC curve showed that the sarcopenia index was a determinant of sarcopenia (cutoff value −1.0634, area under the curve 0.901, sensitivity 96.9%, specificity 70.9%). GDF-15 and myostatin are associated with skeletal muscle volume in patients receiving cardiovascular surgery, but these associations are different. The sarcopenia index calculated from GDF-15 and myostatin levels may be a biomarker of sarcopenia.
登录
查看更多内容
DOI:
10.1016/j.ijcha.2020.100651
发表时间:
2020-12
期刊:
International journal of cardiology. Heart & vasculature
影响因子:
--
作者:
Yazawa H;Fukuda T;Kaneda H;Waku R;Sakuma M;Matsumoto A;Toyoda S;Abe S;Nakamura F;Inoue T;Nakajima T
通讯作者:
Nakajima T
影响因子:
39.3
作者:
Fuelster, Susann;Tacke, Matthias;von Haehling, Stephan
通讯作者:
von Haehling, Stephan
DOI:
10.1016/s0735-1097(02)01736-9
发表时间:
2002-04-03
影响因子:
24
作者:
Hambrecht, R;Schulze, PC;Schuler, G
通讯作者:
Schuler, G
影响因子:
37.8
作者:
Shimura, Tetsuro;Yamamoto, Masanori;Hayashida, Kentaro
通讯作者:
Hayashida, Kentaro
影响因子:
3.5
作者:
Furihata, Takaaki;Kinugawa, Shintaro;Tsutsui, Hiroyuki
通讯作者:
Tsutsui, Hiroyuki